Subscribe
4 min read

Digital Therapeutics (DTx) for Mental Health Market to Experience Rapid Growth by 2030 As Revealed In New Report

Digital Therapeutics (DTx) for Mental Health Market to Experience Rapid Growth by 2030 As Revealed In New Report unknown

Guest Post By

Insightace Analytic Medical and Health Markets 2024-08-21

InsightAce Analytic Pvt. Ltd. has released an in-depth market assessment report on the "Global Digital Therapeutics (DTx) for Mental Health Market," forecasting a robust growth trajectory with an anticipated CAGR of 27.42% through 2030.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Digital Therapeutics (DTx) for Mental Health Market Size, Share & Trends Analysis Report By Application (Treatment/Care Related, Preventive Care), By Disease Indication (Anxiety Disorder, Depression, Bipolar Disorder, Post-Traumatic Stress Disorder, Others), By Sales Channel (Payers, Pharmaceutical Companies, Providers, Caregivers, Patients), Region, Market Outlook And Industry Analysis 2031"

The global Digital Therapeutics (DTx) for Mental Health Market is estimated to exhibit a CAGR of 27.42% during the forecast period. 

Get Free Access to Demo Report, Excel Pivot and ToC: www.insightaceanalytic.com/request-sample/1899

DTx products offer people the tools they need to actively manage their mental health. Users who want to enhance their well-being can track their symptoms, create goals, access educational resources, and learn coping mechanisms. DTx systems frequently offer in-the-moment feedback and progress tracking, enabling users to keep tabs on their personal development and make wise choices regarding their mental health. With illnesses like depression, anxiety, and stress-related disorders becoming more prevalent, the worldwide burden of mental health disorders has been increasing. Due to the huge demand this has generated for affordable and successful mental health interventions, the DTx market is expanding.

Digital treatments are flourishing now that cell phones are so widely used and high-speed internet is so easily accessible. Delivering personalized and interesting mental health therapies is now possible because of the development of mobile apps, wearable technology, and remote monitoring technologies. Moreover, the regulatory environment for digital therapies is constantly changing. Regulatory bodies are currently establishing procedures for the approval and control of DTx products, including the U.S.

Food and Drug Administration (FDA). The market is being further encouraged by the adaptation of reimbursement rules to accommodate digital therapies.

List of Prominent Players in the Digital Therapeutics (DTx) for Mental Health Market:

  • Noom
  • Teladoc Health
  • Omada Health
  • WellDoc
  • Pear Therapeutics
  • COGNIFIT
  • Ginger
  • Propeller Health
  • 2morrow
  • Canary Health.

Expert Knowledge, Just a Click Away: calendly.com/insight…th=2024-02

Market Dynamics:

Drivers-

With a focus on patient-centered treatment and self-management, the healthcare environment is changing. DTx solutions support these changes by enabling people to actively participate in their mental health by providing tools for self-monitoring, goal planning, and skill development. They are consistent with a broader trend towards individualized, patient-centered mental treatment. The potential of DTx for mental health is becoming more and more recognized by regulatory organizations and healthcare systems. Innovation and commercial expansion have been spurred by cooperation between technology businesses, pharmaceutical corporations, and healthcare providers.

Challenges:

Market entrance and coverage are challenged by the regulatory and reimbursement landscape for DTx treatments, which is currently developing. To create a streamlined procedure for DTx solution providers, it is necessary to provide clear criteria and paths for regulatory clearance and reimbursement. Market obstacles and uncertainty may make it difficult for DTx solutions to be adopted and used if suitable regulations and compensation are not in place. Interoperability problems, resistance to change, and the necessity for DTx intervention use training and education are a few examples of integration obstacles.

Regional Trends:

The North America Digital Therapeutics (DTx) for Mental Health Market is expected to register a major market share in terms of revenue and is projected to grow at a high CAGR in the near future, owing to the established healthcare systems that are progressively incorporating digital therapies for mental health. To facilitate access, reimbursement, and implementation of DTx interventions, this integration involves partnerships with healthcare providers, insurance providers, and employers. To facilitate the integration of DTx into current care models, virtual mental health clinics, telepsychiatry services, and digital health platforms are being used. The potential of DTx therapies has been acknowledged by regulatory organizations in North America, notably the U.S. Food and Drug Administration (FDA) and Health Canada, who have built frameworks for their clearance and regulation. For instance, the FDA provides a particular regulatory pathway for digital pharmaceuticals that offer a shortened procedure for market entrance. The development and acceptability of DTx treatments for mental health have benefited from this regulatory assistance.

 

Recent Developments:

  • In June 2021, A definitive agreement was reached between Novartis and Akili Interactive Labs, a business that specializes in creating digital therapies for the treatment of neurological and psychiatric diseases. Through the acquisition, Novartis will have access to Akili's digital therapeutics platform, which has a portfolio of digital therapeutics programs in development as well as a library of clinical evidence.

Unlock Your GTM Strategy: www.insightaceanalytic.com/customisation/1899

Segmentation of Digital Therapeutics (DTx) for Mental Health Market-

By Sales Channel Type-

  • Treatment/care Related
  • Preventive Care

By Disease Indication-

  • Anxiety Disorder
  • Depression
  • Bipolar Disorder
  • Post-Traumatic Stress Disorder
  • Others

By Sales Channel-

  • Payers
  • Pharmaceutical Companies
  • Providers
  • Caregivers
  • Patients

By Region-

North America-

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

 

Empower Your Decision-Making with 180 Pages Full Report @ www.insightaceanalytic.com/buy-report/1899

.

News From

InsightAce AnalyticCategory: Industry Reports & Market Analysis Profile: Excel in niche and complex market studies with high-quality market research reports. Our market intelligence reports service will address your niche market needs to identify opportunities for future business growth. InsightAce Analytic can acquire any customized market data or intelligence reports to support the client's strategic planning process.

This email address is being protected from spambots. You need JavaScript enabled to view it.

Published by: